These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38039492)

  • 1. Parathyroidectomy: still the best choice for the management of severe secondary hyperparathyroidism.
    Ramos LGF; Cortes DDPVR; Reis LMD; Montenegro FLM; Arap SS; Brescia MDG; Custódio MR; Jorgetti V; Elias RM; Moysés RMA
    J Bras Nefrol; 2024; 46(2):e20230024. PubMed ID: 38039492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism.
    Kim WW; Rhee Y; Kim BS; Kim K; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    Endocr J; 2019 Oct; 66(10):881-889. PubMed ID: 31189770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial.
    Wang AY; Lo WK; Cheung SC; Tang TK; Yau YY; Lang BH
    Nephrol Dial Transplant; 2023 Jul; 38(8):1823-1835. PubMed ID: 36869794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism.
    Egan CE; Qazi M; Lee J; Lee-Saxton YJ; Greenberg JA; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
    J Surg Res; 2023 Nov; 291():330-335. PubMed ID: 37506432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Management of Secondary Hyperparathyroidism and the Role of Surgery: A 5-Year Retrospective Study.
    Sevva C; Divanis D; Tsinari A; Grammenos P; Laskou S; Mantalobas S; Paschou E; Magra V; Kopsidas P; Kesisoglou I; Liakopoulos V; Sapalidis K
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792994
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
    Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
    Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroidectomy vs Cinacalcet Among Patients Undergoing Hemodialysis.
    Komaba H; Hamano T; Fujii N; Moriwaki K; Wada A; Masakane I; Nitta K; Fukagawa M
    J Clin Endocrinol Metab; 2022 Jun; 107(7):2016-2025. PubMed ID: 35277957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of parathyroidectomy versus calcimimetics for secondary hyperparathyroidism and kidney transplantation: a propensity-matched analysis.
    Koh EY; van der Plas WY; Dulfer RR; Pol RA; Kruijff S; Rotmans JI; Appelman-Dijkstra N; Schepers A; de Borst MH; Hoorn EJ; van Ginhoven TM; Nieveen van Dijkum EJM; Vogt L; Engelsman AF;
    Langenbecks Arch Surg; 2020 Sep; 405(6):851-859. PubMed ID: 32778916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
    Parfrey PS; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Dehmel B; Trotman ML; Modafferi DM; Goodman WG
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kidney and bone update : the 5-year history and future of CKD-MBD. Parathyroidectomy for secondary hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2012 Jul; 22(7):1083-8. PubMed ID: 22750941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.
    Chen L; Wang K; Yu S; Lai L; Zhang X; Yuan J; Duan W
    Ren Fail; 2016 Aug; 38(7):1050-8. PubMed ID: 27198474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis.
    McManus C; Oh A; Lee JA; Hur C; Kuo JH
    Surgery; 2021 Jan; 169(1):94-101. PubMed ID: 32732069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics.
    Tominaga Y; Matsuoka S; Uno N; Sato T
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S21-6. PubMed ID: 19032523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism.
    van der Plas WY; Engelsman AF; Özyilmaz A; van der Horst-Schrivers AN; Meijer K; van Dam GM; Pol RA; de Borst MH; Kruijff S
    Ann Surg Oncol; 2017 Jan; 24(1):15-22. PubMed ID: 27459979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy.
    Rivelli GG; Lima ML; Mazzali M
    J Bras Nefrol; 2020; 42(3):315-322. PubMed ID: 32720971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes.
    Mathur A; Sutton W; Ahn JB; Prescott JD; Zeiger MA; Segev DL; McAdams-DeMarco M
    Transplantation; 2021 Dec; 105(12):e366-e374. PubMed ID: 33534525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Moldovan D; Racasan S; Kacso IM; Rusu C; Potra A; Bondor C; Patiu IM; Gherman-Căprioară M
    Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis.
    Dulfer RR; Koh EY; van der Plas WY; Engelsman AF; van Dijkum EJMN; Pol RA; Vogt L; de Borst MH; Kruijff S; Schepers A; Appelman-Dijkstra NM; Rotmans JI; Hesselink DA; van Eijck CHJ; Hoorn EJ; van Ginhoven TM;
    Langenbecks Arch Surg; 2019 Feb; 404(1):71-79. PubMed ID: 30729318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.